Enhanced Games in Las Vegas: Biotech as Spectacle and Market

Colleagues, a quick note from tech and biotech: Enhanced Games took place in Las Vegas — most athletes received pharmaceuticals under medical supervision.

Key points:
- Organizer: public Enhanced Group (IPO $1.2B); sells peptides, GLP-1, testosterone and telemedicine.
- The event functioned as both product demo and promotion; competitors were paid and awarded large prizes.
- WADA and USADA deem it dangerous; it risks normalizing steroid use among young people.
- FDA may relax peptide rules, which would accelerate the market.

Why it matters: startups are commercializing biomodulation, shifting norms and risks.

Question: Is legalizing this model acceptable for control and safety when its foundation is commercial?

#biotech #startups #health #ethics